Education
About Us
Working with TipRanks
Follow Us
Cardiol Therapeutics (CRDL)
NASDAQ:CRDL
CRDL Analyst Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CRDL Stock 12 Month Forecast
Average Price Target
$8.00
▲(700.00% Upside)
| Highest Price Target$9.00 | Average Price Target$8.00 | Lowest Price Target$7.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
Reiterated
02/24/25
Rodman & Renshaw
Initiated
01/28/25
Canaccord Genuity
$8
Buy
700.00%
Upside
Reiterated
11/20/24
Edward Nash Reaffirms Buy Rating for Cardiol Therapeutics: Positive Phase II Data and Strategic Future Trials Boost Market Potential
Roth MKM
$10
Buy
900.00%
Upside
Reiterated
10/23/24
Cardiol Therapeutics (CRDL) Gets a Buy from Roth MKM
Unknown Analyst
Not Ranked
B.Riley Financial
$10
Buy
900.00%
Upside
Initiated
06/26/24
Cardiol Therapeutics initiated with a Buy at B. RileyCardiol Therapeutics initiated with a Buy at B. Riley
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
Reiterated
02/24/25
Rodman & Renshaw
Initiated
01/28/25
Canaccord Genuity
$8
Buy
700.00%
Upside
Reiterated
11/20/24
Edward Nash Reaffirms Buy Rating for Cardiol Therapeutics: Positive Phase II Data and Strategic Future Trials Boost Market Potential
Roth MKM
$10
Buy
900.00%
Upside
Reiterated
10/23/24
Cardiol Therapeutics (CRDL) Gets a Buy from Roth MKM
Unknown Analyst
Not Ranked
B.Riley Financial
$10
Buy
900.00%
Upside
Initiated
06/26/24
Cardiol Therapeutics initiated with a Buy at B. RileyCardiol Therapeutics initiated with a Buy at B. Riley
CRDL Analyst Recommendation Trends
Rating
Oct 24
Nov 24
Dec 24
Jan 25
Feb 25
Strong Buy
8
6
6
4
3
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
6
6
4
3
Each month's total comprises the sum of three months' worth of ratings.
CRDL Financial Forecast
CRDL Stock Forecast FAQ
What is CRDL’s average 12-month price target, according to analysts?
Based on analyst ratings, Cardiol Therapeutics’s 12-month average price target is $8.00.
What is CRDL’s upside potential, based on the analysts’ average price target?
Cardiol Therapeutics has 700.00% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CRDL a Buy, Sell or Hold?
Cardiol Therapeutics has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Cardiol Therapeutics’s price target?
The average price target for Cardiol Therapeutics is $8.00. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $9.00 ,the lowest forecast is $7.00. The average price target represents 700.00% Increase from the current price of $1.
The highest analyst price target is $9.00 ,the lowest forecast is $7.00. The average price target represents 700.00% Increase from the current price of $1.
What do analysts say about Cardiol Therapeutics?
Cardiol Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of CRDL?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.